Recent Insider Transactions - Acrivon Therapeutics (NASDAQ: ACRV)

Company

Name / Role

Date

Type

Price

# Shares

Value

Balance

NASDAQ ACRV Acrivon Therapeutics

Blume-Jensen Peter / director, officer: President and CEO

11/21/2025

Sell

$2.30

19,904

$46K

2.05M

NASDAQ ACRV Acrivon Therapeutics

Peterson Katharine / officer: Chief Accounting Officer

11/14/2025

Sell

$2.24

$222

4,122

NASDAQ ACRV Acrivon Therapeutics

Miller Mary / officer: Chief Legal Officer

11/14/2025

Sell

$2.24

184

$412

34,555

NASDAQ ACRV Acrivon Therapeutics

Gamelin Erick / officer: Chief Development Officer

11/14/2025

Sell

$2.24

403

$903

15,283

NASDAQ ACRV Acrivon Therapeutics

Devroe Eric / officer: Chief Operating Officer

11/14/2025

Sell

$2.24

613

$1K

65,308

NASDAQ ACRV Acrivon Therapeutics

Blume-Jensen Peter / director, officer: President and CEO

11/14/2025

Sell

$2.24

59,765

$134K

2.07M

NASDAQ ACRV Acrivon Therapeutics

Blume-Jensen Peter / director, officer: President and CEO

11/14/2025

Sell

$2.24

490

$1K

314,706

NASDAQ ACRV Acrivon Therapeutics

Miller Mary / officer: Chief Legal Officer

10/17/2025

Sell

$1.81

558

$1K

34,739